ArticleOpen medicine (Warsaw, Poland)2022

circ-LIMK1 regulates cisplatin resistance in lung adenocarcinoma by targeting miR-512-5p/HMGA1 axis.

Ya Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.